As of 2024-12-14, the EV/EBITDA ratio of StageZero Life Sciences Ltd (SZLS.TO) is -4.16. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SZLS.TO's latest enterprise value is 7.85 mil CAD. SZLS.TO's TTM EBITDA according to its financial statements is -1.88 mil CAD. Dividing these 2 quantities gives us the above SZLS.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |